These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

433 related items for PubMed ID: 12969811

  • 1. Mild to moderate reduction of a von Willebrand factor cleaving protease (ADAMTS-13) in pregnant women with HELLP microangiopathic syndrome.
    Lattuada A, Rossi E, Calzarossa C, Candolfi R, Mannucci PM.
    Haematologica; 2003 Sep; 88(9):1029-34. PubMed ID: 12969811
    [Abstract] [Full Text] [Related]

  • 2. [Activity loss of Von Willebrand factor cleaving protein (ADAMTS-13) is diagnostic for primary and pregnancy-related thrombotic thrombocytopenic purpura].
    Hulstein JJ, Rison CN, Kappers-Klunne MC, Hene RJ, Franx A, de Groot PG, Brand A, Fijnheer R.
    Ned Tijdschr Geneeskd; 2004 Oct 02; 148(40):1972-6. PubMed ID: 15524133
    [Abstract] [Full Text] [Related]

  • 3. Deficient activity of von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura.
    Furlan M.
    Expert Rev Cardiovasc Ther; 2003 Jul 02; 1(2):243-55. PubMed ID: 15030284
    [Abstract] [Full Text] [Related]

  • 4. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease.
    Furlan M, Lämmle B.
    Best Pract Res Clin Haematol; 2001 Jun 02; 14(2):437-54. PubMed ID: 11686108
    [Abstract] [Full Text] [Related]

  • 5. The von Willebrand factor-cleaving protease (ADAMTS-13) and the diagnosis of thrombotic thrombocytopenic purpura (TTP).
    Kremer Hovinga JA, Studt JD, Lämmle B.
    Pathophysiol Haemost Thromb; 2001 Jun 02; 33(5-6):417-21. PubMed ID: 15692254
    [Abstract] [Full Text] [Related]

  • 6. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
    Furlan M, Robles R, Galbusera M, Remuzzi G, Kyrle PA, Brenner B, Krause M, Scharrer I, Aumann V, Mittler U, Solenthaler M, Lämmle B.
    N Engl J Med; 1998 Nov 26; 339(22):1578-84. PubMed ID: 9828245
    [Abstract] [Full Text] [Related]

  • 7. Assay of von Willebrand factor (vWF)-cleaving protease based on decreased collagen binding affinity of degraded vWF: a tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP).
    Gerritsen HE, Turecek PL, Schwarz HP, Lämmle B, Furlan M.
    Thromb Haemost; 1999 Nov 26; 82(5):1386-9. PubMed ID: 10595623
    [Abstract] [Full Text] [Related]

  • 8. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura.
    Tsai HM, Lian EC.
    N Engl J Med; 1998 Nov 26; 339(22):1585-94. PubMed ID: 9828246
    [Abstract] [Full Text] [Related]

  • 9. von Willebrand factor cleaving protease (ADAMTS-13) and ADAMTS-13 neutralizing autoantibodies in 100 patients with thrombotic thrombocytopenic purpura.
    Peyvandi F, Ferrari S, Lavoretano S, Canciani MT, Mannucci PM.
    Br J Haematol; 2004 Nov 26; 127(4):433-9. PubMed ID: 15521921
    [Abstract] [Full Text] [Related]

  • 10. von Willebrand factor, ADAMTS-13, and thrombotic thrombocytopenic purpura.
    Moake JL.
    Semin Hematol; 2004 Jan 26; 41(1):4-14. PubMed ID: 14727254
    [Abstract] [Full Text] [Related]

  • 11. Recent advances in thrombotic thrombocytopenic purpura.
    Sadler JE, Moake JL, Miyata T, George JN.
    Hematology Am Soc Hematol Educ Program; 2004 Jan 26; ():407-23. PubMed ID: 15561695
    [Abstract] [Full Text] [Related]

  • 12. [Clinical features and laboratory findings of thrombotic thrombocytopenic purpura associated with ticlopidine].
    Yagi H.
    Rinsho Byori; 2005 Jul 26; 53(7):630-8. PubMed ID: 16104532
    [Abstract] [Full Text] [Related]

  • 13. Measurement of von Willebrand factor cleaving protease (ADAMTS-13): results of an international collaborative study involving 11 methods testing the same set of coded plasmas.
    Tripodi A, Chantarangkul V, Böhm M, Budde U, Dong JF, Friedman KD, Galbusera M, Girma JP, Moake J, Rick ME, Studt JD, Turecek PL, Mannucci PM.
    J Thromb Haemost; 2004 Sep 26; 2(9):1601-9. PubMed ID: 15333037
    [Abstract] [Full Text] [Related]

  • 14. Thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome.
    Moake JL.
    Arch Pathol Lab Med; 2002 Nov 26; 126(11):1430-3. PubMed ID: 12421153
    [Abstract] [Full Text] [Related]

  • 15. Severe HELLP syndrome masquerading as thrombocytopenic thrombotic purpura: a case report.
    Mousseaux C, Joly BS, Mohamadou I, Arrestier R, Hertig A, Rafat C.
    BMC Nephrol; 2020 May 29; 21(1):204. PubMed ID: 32471388
    [Abstract] [Full Text] [Related]

  • 16. Increased plasma von Willebrand factor antigen levels but normal von Willebrand factor cleaving protease (ADAMTS13) activity in preeclampsia.
    Molvarec A, Rigó J, Bõze T, Derzsy Z, Cervenak L, Makó V, Gombos T, Udvardy ML, Hársfalvi J, Prohászka Z.
    Thromb Haemost; 2009 Feb 29; 101(2):305-11. PubMed ID: 19190814
    [Abstract] [Full Text] [Related]

  • 17. Von Willebrand factor cleaving protease (ADAMTS-13) in 123 patients with connective tissue diseases (systemic lupus erythematosus and systemic sclerosis).
    Mannucci PM, Vanoli M, Forza I, Canciani MT, Scorza R.
    Haematologica; 2003 Aug 29; 88(8):914-8. PubMed ID: 12935979
    [Abstract] [Full Text] [Related]

  • 18. Measurement of von Willebrand factor-cleaving protease (ADAMTS-13) activity in plasma: a multicenter comparison of different assay methods.
    Studt JD, Böhm M, Budde U, Girma JP, Varadi K, Lämmle B.
    J Thromb Haemost; 2003 Sep 29; 1(9):1882-7. PubMed ID: 12941027
    [Abstract] [Full Text] [Related]

  • 19. Acute activation of the endothelium results in increased levels of active von Willebrand factor in hemolysis, elevated liver enzymes and low platelets (HELLP) syndrome.
    Hulstein JJ, van Runnard Heimel PJ, Franx A, Lenting PJ, Bruinse HW, Silence K, de Groot PG, Fijnheer R.
    J Thromb Haemost; 2006 Dec 29; 4(12):2569-75. PubMed ID: 16968329
    [Abstract] [Full Text] [Related]

  • 20. von Willebrand factor-cleaving protease (ADAMTS-13) activity determination in the diagnosis of thrombotic microangiopathies: the Swiss experience.
    Kremer Hovinga JA, Studt JD, Alberio L, Lämmle B.
    Semin Hematol; 2004 Jan 29; 41(1):75-82. PubMed ID: 14727262
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.